Moti Investments reports 6.1% Elicio stake

Moti Investments LLC is reported as a significant shareholder of Elicio Therapeutics, Inc., with beneficial ownership of 1,408,892 shares of common stock, par value $0.01 per share.

Rhea-AI Filing Summary

Moti Investments LLC is reported as a significant shareholder of Elicio Therapeutics, Inc., with beneficial ownership of 1,408,892 shares of common stock, par value $0.01 per share. This position represents 6.1% of Elicio’s common stock class.

Moti Investments, organized in Saint Kitts and Nevis and based in Dubai, has sole voting power and sole dispositive power over all 1,408,892 shares, with no shared voting or dispositive power. The report is signed by Manager Kalpana H. Jogani, dated July 16, 2026.

Key Figures

Beneficially owned shares: 1,408,892 shares Ownership percentage: 6.1% Sole voting power: 1,408,892 shares +3 more

6 metrics

Beneficially owned shares 1,408,892 shares Common Stock beneficially owned by Moti Investments LLC

Ownership percentage 6.1% Percent of Elicio Therapeutics common stock class held by Moti Investments LLC

Sole voting power 1,408,892 shares Shares for which Moti Investments LLC has sole power to vote or direct the vote

Shared voting power 0 shares Shares for which Moti Investments LLC has shared power to vote

Sole dispositive power 1,408,892 shares Shares for which Moti Investments LLC has sole power to dispose or direct disposition

Shared dispositive power 0 shares Shares for which Moti Investments LLC has shared power to dispose

Key Terms

beneficially owned, sole power to vote or to direct the vote, sole power to dispose or to direct the disposition, Schedule 13G

4 terms

beneficially owned financial

"Ownership (a) | Amount beneficially owned: 1,408,892"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole power to vote or to direct the vote financial

"Number of shares as to which the person has | (i) Sole power to vote or to direct the vote"

sole power to dispose or to direct the disposition financial

"(iii) Sole power to dispose or to direct the disposition of: 1,408,892"

Schedule 13G regulatory

"Elicio Therapeutics, Inc. ... SCHEDULE 13G ownership report by Moti Investments LLC"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Moti Investments LLC report in Elicio Therapeutics (ELTX)?

Moti Investments LLC reports beneficial ownership of 1,408,892 Elicio Therapeutics common shares, representing 6.1% of the class. This Schedule 13G reflects a significant shareholder position with sole voting and dispositive power over all reported shares.

What percentage of Elicio Therapeutics (ELTX) common stock is owned by Moti Investments?

Moti Investments LLC reports holding 6.1% of Elicio Therapeutics’ common stock class. This percentage is based on 1,408,892 shares beneficially owned, as disclosed in the Schedule 13G ownership section for the company’s common stock.

Does Moti Investments share voting or dispositive power over ELTX shares?

Moti Investments LLC reports sole voting power and sole dispositive power over all 1,408,892 Elicio Therapeutics shares. The filing shows 0 shares with shared voting power and 0 shares with shared dispositive power, indicating exclusive control over the reported stake.

Where is Moti Investments LLC, the ELTX shareholder, organized and located?

Moti Investments LLC is organized in Saint Kitts and Nevis, with its principal business office at 392 Marsa Dubai, Flat 1006, Dubai, United Arab Emirates. This information is disclosed in the Schedule 13G identifying details for the reporting person.

Who signed the Schedule 13G for Moti Investments LLC regarding Elicio Therapeutics (ELTX)?

The Schedule 13G is signed by Kalpana H. Jogani, in the capacity of Manager of Moti Investments LLC. The signature section shows the execution date as July 16, 2026, confirming the certification of the reported ownership details.

What class of Elicio Therapeutics (ELTX) securities is reported by Moti Investments?

Moti Investments LLC reports holdings in Elicio Therapeutics’ Common Stock, par value $0.01 per share. The Schedule 13G lists this security class along with the CUSIP 28657F103 as the subject of the reported beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 11:42 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Elicio Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

28657F103

(CUSIP Number)

07/01/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 28657F103

1

Names of Reporting Persons

Moti Investments LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

SAINT KITTS AND NEVIS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,408,892.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,408,892.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,408,892.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Elicio Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 451 D STREET, 5TH FLOOR, BOSTON, MASSACHUSETTS, 02210
Item 2.
(a)	Name of person filing: Moti Investments LLC
(b)	Address or principal business office or, if none, residence: 392 Marsa Dubai, Flat 1006, Dubai, United Arab Emirates
(c)	Citizenship: Saint Kitts and Nevis
(d)	Title of class of securities: Common Stock, par value $0.01 per share
(e)	CUSIP Number(s): 28657F103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,408,892
(b)	Percent of class: 6.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,408,892
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,408,892
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Moti Investments LLC

Signature:	/s/ Kalpana H. Jogani
Name/Title:	Manager
Date:	07/16/2026